Novo Nordisk A/S ADR buy fenjal
Start price
29.05.23
/
50%
€154.00
Target price
29.05.24
-
Performance (%)
10.06%
End price
16.08.23
€169.50
Summary
This prediction ended on 16.08.23 with a price of €169.50. The BUY prediction by fenjal finished with a performance of 10.06%. fenjal has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novo Nordisk A/S ADR | -2.467% | -2.467% | -15.150% | -76.534% |
| iShares Core DAX® | -1.586% | 5.028% | 6.332% | 64.061% |
| iShares Nasdaq 100 | -4.148% | -0.125% | 25.735% | 86.918% |
| iShares Nikkei 225® | -6.302% | 0.528% | 41.384% | 77.872% |
| iShares S&P 500 | -3.225% | 0.470% | 20.449% | 68.192% |
According to fenjal what are the pros and cons of Novo Nordisk A/S ADR for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by fenjal for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Buy Novo Nordisk A/S ADR
In the thread Trading Novo Nordisk A/S ADR
Buy beendet
Stopped prediction by fenjal for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€79.00
20.12.24
20.12.24
-
20.12.25
20.12.25
7.85%
10.01.25
10.01.25
Could be worthwhile Investment >10% per year
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€37.03
09.05.17
09.05.17
€42.00
18.09.17
18.09.17
10.53%
18.09.17
18.09.17
Could be worthwhile Investment >10% per year


